Price history
¥3,760Latest-58.8%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
217.58How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
2.96How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
1.4%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥246bnShare price × number of shares. The value of the entire company.Equity ratio
53.9%The proportion of assets funded by money that does not have to be repaid.Operating margin
14.5%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
23.5%The average annual growth in sales over the past three years.What to watch next
Continued growth in the number of PepUp IDs issued, together with ARPU improvement driven by wearable-device connectivity, data integration and analysis, including more advanced outcome prediction
The next 12–18 months, aligned with ongoing KPI update cyclesImpact MediumLikelihood Medium
Activation of an analytical environment integrating activity levels, genomic data and other information, expanding the range of causal-relationship analysis that can be provided, and the resulting changes in pricing per data-use engagement and contract size
18–30 monthsImpact HighLikelihood Low
Additional AI-RAD functionality being incorporated into teleradiology service offerings, including interpretation support, matching and ASP, leading to improvements in activity levels, such as examinations, cases and facilities, and retention rates
The next 12–24 monthsImpact MediumLikelihood Medium
Confirmation of whether monetization is brought forward or delayed following completion of equipment and system development investment in the remote healthcare segment, based on progress against the investment plan
After the investment scheduled to begin in April 2026 and be completed in March 2027Impact MediumLikelihood Medium
Tightening of procedures for personal information protection and anonymized processed information, and the occurrence or absence of serious information-security incidents involving personal-information breaches or external contractors
Ongoing, event-drivenImpact HighLikelihood Low
What to watch next
Who owns itTop holders total 78.3%
Listed holders 78.3%Everyone else 21.7%
OMRON Corporation54.19%
The Master Trust Bank of Japan, Ltd. (Trust Account)6.30%
株式会社日本カストディ銀行 (Trust Account)5.54%
Noritsu Koki Co.,Ltd.4.55%
INDUS SELECT MASTER FUND, LTD.3.43%
BNP PARIBAS LUXEMBOURG/2S/JASDEC SECURITIES/UCITS ASSETS1.05%
NORTHERN TRUST CO.(AVFC) RE UKUC UCITS CLIENTS NON LENDING 10PCT TREATY ACCOUNT0.89%
Matsushima Yosuke (松島 陽介)0.86%
2 other listed holders1.51%
| Holder | Ownership (%) |
|---|---|
| OMRON Corporation | 54.19 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 6.30 |
| 株式会社日本カストディ銀行 (Trust Account) | 5.54 |
| Noritsu Koki Co.,Ltd. | 4.55 |
| INDUS SELECT MASTER FUND, LTD. | 3.43 |
| BNP PARIBAS LUXEMBOURG/2S/JASDEC SECURITIES/UCITS ASSETS | 1.05 |
| NORTHERN TRUST CO.(AVFC) RE UKUC UCITS CLIENTS NON LENDING 10PCT TREATY ACCOUNT | 0.89 |
| Matsushima Yosuke (松島 陽介) | 0.86 |
| 2 other listed holders | 1.51 |
This company's documents
Filings
Timely disclosures
- 2026-09-18JMDC confirms that recording body composition and blood pressure measurements in a PHR may improve weight and blood pressure
- 2026-09-16JMDC Publishes the “2026 Edition JMDC Health and Productivity Management KPI Guidebook,” Using One of Japan’s Largest Medical Big Data Sets
- 2026-09-10Kurashiki Central Hospital and Real World Data Demonstrate the Efficiency Gains from Using Electronic Worksheets (eWS) in Clinical Trial Operations with Actual Figures from a Live Clinical Trial
- 2026-08-05Earnings Presentation Materials for the First Quarter of the Fiscal Year Ending March 2027
- 2026-08-05Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 (IFRS, Consolidated)
- 2026-07-16Notice Regarding the Finalization of the Terms of the Issuance of Subscription Rights to Shares (Stock Options)
- 2026-06-30Mitsubishi UFJ Bank, OMRON and JMDC collaborate to promote regular blood pressure measurement among approximately 30,000 employees: using PHRs (Personal Health Records) to advance self-care and health and productivity management
- 2026-06-29JMDC launches project with Zene and Maruho to elucidate the fundamental factors underlying skin pathophysiology using genetic statistical analysis and large-scale medical big data
12 more
- 2026-06-25Matters Concerning Controlling Shareholders
- 2026-06-25Notice Regarding the Issuance of New Share Subscription Rights (Stock Options)
- 2026-06-24JMDC, OMRON and the University of Tsukuba develop a highly accurate model for predicting the risk of sleep apnea syndrome (SAS) using claims, health checkup and lifelog data
- 2026-06-01Other Matters Subject to Electronic Provision for the 13th Annual General Meeting of Shareholders
- 2026-06-01Notice of Convocation of the 13th Annual General Meeting of Shareholders
- 2026-05-29JMDC and Sumitomo Life Publish “Health Promotion White Paper” on the Health Impact of 1,000 Additional Steps a Day: Links to Health Screening Results, Number of Hospitalizations and Medical Costs Revealed
- 2026-05-08Notice Concerning Dividend of Surplus
- 2026-05-08Summary of Financial Results for the Fiscal Year Ending March 2026 (IFRS) (Consolidated)
- 2026-05-08Full-Year Financial Results Presentation for the Fiscal Year Ending March 2026
- 2026-04-22JMDC and Sumitomo Life Insurance Company Present Latest Findings from the “Heatstroke White Paper” at the Japanese Society for Hygiene — Study Reveals the Relationship Between Health, Lifestyle Habits and Heatstroke
- 2026-03-30JMDC renews its occupational health support service, Pep Up for WORK, transforming it into a PHR-integrated health management system linked to Pep Up
- 2026-03-09JMDC、「健康経営優良法人 2026 ~ホワイト500~」に認定
Threads
- 2026-09-18Healthcare Big Data Analytics, PHR and Data Utilisation
- 2026-09-16Co-creation and Implementation of Health and Productivity Management Solutions through the Health and Productivity Management Alliance
- 2026-09-10Business Expansion into the Clinical Trials Sector
- 2026-08-05Improving the Sustainability of National Healthcare Expenditure
- 2026-08-05Expansion of Health Insurance Societies, PeP Up and Data Utilization for Companies
- 2026-08-05Cloud-Based Matching Platform for Remote Radiology Interpretation
- 2026-08-05Expansion of Contracted Radiologists and Contracted Medical Institutions
- 2026-08-05Full-scale rollout of telemedicine operations in China
53 more
- 2026-08-05Performance Evaluation Using EBITDA
- 2026-08-05Revenue and earnings growth underpinned by three businesses
- 2026-08-0510 million members of partner companies’ health insurance associations
- 2026-08-05Development of the AI-RAD Diagnostic Assistance Platform
- 2026-08-05Expansion and enhancement of services for medical institutions
- 2026-08-05Seasonal fluctuations in revenue and profit
- 2026-08-05Share Dilution from the Exercise of Stock Acquisition Rights
- 2026-08-05Maintaining its position as the largest and best healthcare database available for private-sector use
- 2026-08-05Maximizing Transaction Value from Data Utilization Services through Upselling and Cross-Selling
- 2026-08-05Regaining share among pharmaceutical companies’ medical divisions
- 2026-06-30Strengthening the Health Data and Overseas Businesses through a Capital and Business Alliance with OMRON
- 2026-06-25Consolidated business profit EBITDA exceeding ¥3.2 billion
- 2026-06-25Conflicts of Interest and Independence Risks Arising from Parent-Company Control
- 2026-06-25Protection of General Shareholders by Independent Outside Directors and the Nomination and Compensation Advisory Committee
- 2026-06-25Securing and Developing Highly Skilled Specialist Talent and Performance-Linked Compensation
- 2026-06-24Containing healthcare costs and monetizing interventions by improving their return on investment
- 2026-06-24Expanding the Database and Business Platform Through Acquisitions
- 2026-06-24Unrealized Post-Acquisition Synergies and Goodwill Impairment
- 2026-06-24Priority on Retained Earnings and Future Dividend Policy
- 2026-06-24Capital Management Based on Net Interest-Bearing Debt
- 2026-06-24Research and development in severe disease prevention, polypharmacy, pediatric medicine, and health and productivity management
- 2026-06-24Repayment of Borrowings Through New Share Issuance and Securing Investment Capacity
- 2026-06-24Strengthening staffing and organizational capabilities to capture business opportunities
- 2026-06-24Liquidity Risk
- 2026-06-24Interest Rate Risk from Variable-Rate Borrowings
- 2026-06-24Achieving a 30% ratio of women in management
- 2026-06-242026 Health & Productivity Management Outstanding Organization (White 500) Certification
- 2026-06-24Decline in the Underlying Value of Shares in Affiliated Companies and Valuation Losses
- 2026-05-08Intensifying Sales and Technology Competition from Competitors
- 2026-05-08Specific Health Checkups and Behavior-Change Solutions for National Health Insurance and Municipalities
- 2026-05-08Incorrect Assumptions Underlying the Medium- to Long-Term Management Strategy and Failure to Achieve Plans
- 2025-06-26Development, sales and operational testing of systems for dispensing pharmacies
- 2025-06-26Securing Replacement Demand from Existing Customers and Developing New Customers
- 2025-06-26System Failures and Cybersecurity Breaches
- 2025-06-26Leakage of Personal and Customer Information
- 2025-06-26Changes to Personal Data Protection Regulations and Claims Submission Specifications
- 2025-06-26Misdiagnosis in Teleradiology and Reliance on Contracted Radiologists
- 2025-06-26Recruitment, Development and Retention of Talent
- 2025-06-26Internal Controls, Risk Management, and Audit Collaboration
- 2025-06-26Counterparty Insolvency and Credit Risk
- 2025-06-26Claims relating to data, remote radiology interpretation, and system products
- 2025-06-26Changes in Licensing and Regulations Related to Healthcare and Pharmaceuticals
- 2025-06-26Infringement of, and by, intellectual property rights
- 2025-06-26Utilizing Diverse Talent and Creating a Healthy Workplace Environment
- 2025-06-26Exploring Opportunities to Collect and Use Data Through Holding Heartseed Shares
- 2024-06-26Impact of COVID-19 on Business Performance
- 2024-06-26Joint research aimed at enhancing the anonymity of medical and health data
- 2022-06-22Digitization of Vaccination Records and COVID-19 Severity Risk Analysis
- 2022-06-22Transfer to the Tokyo Stock Exchange Prime Market
- 2022-02-14Transfer to the Tokyo Stock Exchange First Section
- 2020-11-13Reducing the Investment Unit and Improving Liquidity Through a Stock Split
- 2020-06-22Reallocation of IPO proceeds to capital investment and working capital
- 2020-02-13Listing on the Tokyo Stock Exchange Mothers Market and Issuance of New Shares